Follow
Sebastian Schneider
Sebastian Schneider
Verified email at merck.com
Title
Cited by
Cited by
Year
In silico prediction of binding sites on proteins
S Leis, S Schneider, M Zacharias
Current medicinal chemistry 17 (15), 1550-1562, 2010
1052010
Mechanistic insights into the allosteric modulation of opioid receptors by sodium ions
Y Shang, V LeRouzic, S Schneider, P Bisignano, GW Pasternak, ...
Biochemistry 53 (31), 5140-5149, 2014
1022014
How oliceridine (TRV-130) binds and stabilizes a μ-opioid receptor conformational state that selectively triggers G protein signaling pathways
S Schneider, D Provasi, M Filizola
Biochemistry 55 (46), 6456-6466, 2016
982016
CELLmicrocosmos 2.2 MembraneEditor: A Modular Interactive Shape-Based Software Approach To Solve Heterogeneous Membrane Packing Problems
B Sommer, T Dingersen, C Gamroth, SE Schneider, S Rubert, J Krüger, ...
Journal of chemical information and modeling 51 (5), 1165-1182, 2011
692011
Atomic resolution model of the antibody Fc interaction with the complement C1q component
S Schneider, M Zacharias
Molecular Immunology 51 (1), 66-72, 2012
572012
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability
RS Crowley, AP Riley, AM Sherwood, CE Groer, N Shivaperumal, ...
Journal of medicinal chemistry 59 (24), 11027-11038, 2016
422016
Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)
RL Palte, SE Schneider, MD Altman, RP Hayes, S Kawamura, BM Lacey, ...
ACS Medicinal Chemistry Letters, 2020
342020
The Dynamic Process of Drug–GPCR Binding at Either Orthosteric or Allosteric Sites Evaluated by Metadynamics
S Schneider, D Provasi, M Filizola
G Protein-Coupled Receptors in Drug Discovery: Methods and Protocols, 277-294, 2015
292015
ATTRACT and PTOOLS: Open Source Programs for Protein–Protein Docking
S Schneider, A Saladin, S Fiorucci, C Prevost, M Zacharias
Computational Drug Discovery and Design, 221-232, 2012
242012
The Discovery of Two Novel Classes of 5, 5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer
RV Quiroz, MH Reutershan, SE Schneider, D Sloman, BM Lacey, ...
Journal of Medicinal Chemistry, 2021
172021
Scoring optimisation of unbound protein–protein docking including protein binding site predictions
S Schneider, M Zacharias
Journal of Molecular Recognition 25 (1), 15-23, 2012
132012
Combining geometric pocket detection and desolvation properties to detect putative ligand binding sites on proteins
S Schneider, M Zacharias
Journal of structural biology 180 (3), 546-550, 2012
122012
Development of a Flexible and Robust Synthesis of Tetrahydrofuro[3,4-b]furan Nucleoside Analogues
DA Candito, Y Ye, RV Quiroz, MH Reutershan, D Witter, SB Gadamsetty, ...
The Journal of Organic Chemistry, 2021
62021
Predicted mode of Binding of Non-Nitrogenous μ-Opioid Receptor Ligands by Metadynamics
S Schneider, D Provasi, R Saylor, T Prisinzano, M Filizola
Biophysical Journal 110 (3), 90a, 2016
22016
Binding Pathways of a G-Protein Biased μ-opioid Receptor agonist under Clinical Evaluation
S Schneider, D Provasi, M Filizola
Biophysical Journal 3 (110), 591a, 2016
12016
CELLmicrocosmos 2.2: advancements and applications in modeling of three-dimensional PDB membranes
B Sommer, T Dingersen, S Schneider, S Rubert, C Gamroth
Journal of Cheminformatics 2 (Suppl 1), O21, 2010
12010
CELLmicrocosmos 2.2: advancements and applications in modeling of three-dimensional PDB membranes (Conference Abstract)
B Sommer, T Dingersen, S Schneider, S Rubert, C Gamroth
1*2010
CELLmicrocosmos 2.1: a software approach for the modelling of three-dimensional PDB membranes
B Sommer, T Dingersen, S Schneider
Chemistry Central Journal 3 (1), P72, 2009
12009
CELLmicrocosmos 2.1: a software approach for the modelling of three-dimensional PDB membranes (Conference Abstract)
B Sommer, T Dingersen, S Schneider
1*2009
Prmt5 inhibitors
M Machacek, D Witter, C Huang, S Kawamura, S Schneider, M Wan
US Patent App. 17/266,515, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20